Immunohistochemically, CCS tumors have been demonstrated to express melanocytic differentiation-related markers, including HMB45, Melan-A and MiTF (2,20,21), which are not a characteristic of GNET. This evidence concerns the gene MLANA and gastric neuroendocrine tumor, well differentiated, low or intermediate grade.